Your browser doesn't support javascript.
Are vaccine shortages a relevant public health issue in Europe? Results from a survey conducted in the framework of the EU Joint Action on Vaccination.
Filia, Antonietta; Rota, Maria Cristina; Grossi, Adriano; Martinelli, Domenico; Prato, Rosa; Rezza, Giovanni.
  • Filia A; Department of Infectious Diseases, Istituto Superiore di Sanità, Rome, Italy. Electronic address: antonietta.filia@iss.it.
  • Rota MC; Department of Infectious Diseases, Istituto Superiore di Sanità, Rome, Italy.
  • Grossi A; Department of Infectious Diseases, Istituto Superiore di Sanità, Rome, Italy; Section of Hygiene and Preventive Medicine, Università Cattolica del Sacro Cuore, Rome, Italy.
  • Martinelli D; Department of Medical and Surgical Sciences, University of Foggia, Italy; Department of Hygiene, Policlinico Riuniti University Hospital of Foggia, Italy.
  • Prato R; Department of Medical and Surgical Sciences, University of Foggia, Italy; Department of Hygiene, Policlinico Riuniti University Hospital of Foggia, Italy.
  • Rezza G; Department of Infectious Diseases, Istituto Superiore di Sanità, Rome, Italy.
Vaccine ; 40(13): 1987-1995, 2022 03 18.
Article in English | MEDLINE | ID: covidwho-1689017
ABSTRACT
National immunisation programmes require an adequate supply of vaccines to function properly but many countries, globally and in Europe, have reported vaccine shortages. A comprehensive view of vaccine shortages and stockouts in the EU/EEA is missing in the published literature. This study was conducted in the framework of the European Joint Action on Vaccination (EU-JAV). Twenty-eight countries, including 20 EU-JAV consortium member states and an additional 8 EU/EEA countries, were invited to participate in a survey aimed at collecting information on vaccine shortages and stock-outs experienced from 2016 to 2019, their main causes, actions taken, and other aspects of vaccine supply. Twenty-one countries completed the survey (response rate 75%), of which 19 reported at least one shortage/stock-out event. Overall, 115 events were reported, 28 of which led to a change in the national immunisation programme. The most frequently involved vaccines were DT- and dT-containing combination vaccines, hepatitis B, hepatitis A, and BCG vaccines. The median duration of shortages/stock-outs was five months (range <1 month-39 months). Interruption in supply and global shortage were the most frequently indicated causes. Only about half of countries reported having an immunization supply chain improvement plan. Similarly, only about half of countries had recommendations or procedures in place to address shortages/stockouts. The survey also identified the occurrence of shortages/stockouts of other biological products (e.g. diphtheria antitoxin in 12 countries). Public health strategies to assure a stable and adequate vaccine supply for immunization programmes require coordinated actions from all stakeholders, harmonized definitions, strengthening of reporting and monitoring systems, the presence of an immunization supply chain improvement plan in all countries, and procedures or recommendations in place regarding the use of alternative vaccines or vaccination schedules in case of shortages/stockouts.
Subject(s)
Keywords

Full text: Available Collection: International databases Database: MEDLINE Main subject: Public Health / Vaccination Type of study: Observational study Topics: Vaccines / Variants Country/Region as subject: Europa Language: English Journal: Vaccine Year: 2022 Document Type: Article

Similar

MEDLINE

...
LILACS

LIS


Full text: Available Collection: International databases Database: MEDLINE Main subject: Public Health / Vaccination Type of study: Observational study Topics: Vaccines / Variants Country/Region as subject: Europa Language: English Journal: Vaccine Year: 2022 Document Type: Article